Shanghai Genext Medical Technology Co., Ltd.
PrivateLast Round
Series D
Extension
May 1, 2023
Est. Valuation
$125.94M
Total Funding Raised
$94.23M
Company Overview
Shanghai Genext Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D Extension round in May 2023.
Shanghai Genext Medical Technology Co., Ltd. is a medical technology company that provides products and professional services for the organ transplantation industry, including machine perfusion systems, cold storage solutions, and diagnostic reagents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Supply Chain Tracking, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Genext Medical Technology Co., Ltd. Comparables
Compare Shanghai Genext Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bridge to Life | 81% | |
| Terumo Corporation | 81% | |
| Institut Georges Lopez | 81% |
For institutional investors. Book with your work email.
Shanghai Genext Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | May 1, 2023 | ||||
| Series D | May 6, 2021 | ||||
| Strategic | Oct 20, 2020 | ||||
| Series C | Nov 4, 2019 | ||||
| Series B Extension | Mar 1, 2017 | ||||
Series B | Sep 8, 2016 |
For institutional investors. Book with your work email.
Shanghai Genext Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Series D, Strategic |
| Oriza Holdings | Series D |
| CCB International | Series C |
| Shengshan Asset Management | Strategic |
| 6 Dimensions Capital | Series B, Series A |
| Yunfeng Capital | Series D |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2021
$39M round with participation from Oriza Holdings and Yunfeng Capital.
- Oct 20, 2020
Raised capital from Shengshan Asset Management and CCIC Capital.
For institutional investors. Book with your work email.
Shanghai Genext Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Genext Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Genext Medical Technology Co., Ltd. a public or private company?
Shanghai Genext Medical Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Genext Medical Technology Co., Ltd.?
Shanghai Genext Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Genext Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Genext Medical Technology Co., Ltd. worth (valuation)?
Shanghai Genext Medical Technology Co., Ltd.'s valuation is estimated at $125.9M based on funding round data.
Can I buy Shanghai Genext Medical Technology Co., Ltd. stock?
Shanghai Genext Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Genext Medical Technology Co., Ltd.'s last funding round?
Shanghai Genext Medical Technology Co., Ltd.'s most recent funding round was Series D Extension on May 1, 2023.
Who are the main investors in Shanghai Genext Medical Technology Co., Ltd.?
Key investors in Shanghai Genext Medical Technology Co., Ltd. include CCIC Capital, Oriza Holdings, CCB International, Shengshan Asset Management, 6 Dimensions Capital.
Will Shanghai Genext Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Genext Medical Technology Co., Ltd..
How can I track Shanghai Genext Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Genext Medical Technology Co., Ltd.'s shares on secondary markets.